澳大利亚和新西兰重症监护患者中第三性别的流行病学研究
该回顾性观察研究分析了2018至2022年澳大利亚和新西兰重症监护学会成人患者数据库中200个ICU的892,161例入院,其中525例(0.06%)被归类为第三性别。第三性别患者平均年龄低于女性组(59.2±20.0 vs 61.3±18.4岁;P=.02)和男性组(63.2±16.7岁;P<.001),更常见于骨科手术后(第三性别10.1%[95%CI 7.7%-13.0%];女性6.2%[95%CI 6.1%-6.3%];男性4.8%[95%CI 4.7%-4.9%])和药物过量(第三性别8.8%[95%CI 6.5%-11.5%];女性4.2%[95%CI 4.1%-4.2%];男性3.1%[95%CI 3.0%-3.1%])。调整疾病严重度、诊断、治疗限制、年份和医院后,第三性别组与其他组院内死亡率无差异。作者认为,进一步刻画第三性别群体需要改进健康记录中性别和社会性别的记录流程。
要点
- 在892,161例成人ICU入院中,525例(0.06%)被归类为第三性别,分布于所有诊断类别、辖区和医院类型。
- 第三性别患者平均年龄低于女性组(59.2±20.0 vs 61.3±18.4岁;P=.02)和男性组(63.2±16.7岁;P<.001)。
- 第三性别患者骨科手术后入院比例高于女性组和男性组(10.1%[95%CI 7.7%-13.0%] vs 6.2%[95%CI 6.1%-6.3%] vs 4.8%[95%CI 4.7%-4.9%])。
- 第三性别患者药物过量入院比例高于女性组和男性组(8.8%[95%CI 6.5%-11.5%] vs 4.2%[95%CI 4.1%-4.2%] vs 3.1%[95%CI 3.0%-3.1%])。
- 调整疾病严重度、诊断、治疗限制、年份和医院后,第三性别组与其他组院内死亡率无差异。
适用人群与场景
- 2018至2022年澳大利亚和新西兰200个ICU收治的成人患者,记录于澳大利亚和新西兰重症监护学会成人患者数据库。
研究设计与关键结果
- 回顾性观察研究,纳入200个ICU的892,161例成人入院,其中525例(0.06%)被归类为第三性别。
- 第三性别患者平均年龄低于女性组(59.2±20.0 vs 61.3±18.4岁;P=.02)和男性组(63.2±16.7岁;P<.001)。
- 第三性别患者骨科手术后入院比例为10.1%(95%CI 7.7%-13.0%),女性组为6.2%(95%CI 6.1%-6.3%),男性组为4.8%(95%CI 4.7%-4.9%)。
- 第三性别患者药物过量入院比例为8.8%(95%CI 6.5%-11.5%),女性组为4.2%(95%CI 4.1%-4.2%),男性组为3.1%(95%CI 3.0%-3.1%)。
- 采用混合效应逻辑回归调整疾病严重度、诊断、治疗限制、年份和医院后,第三性别组与其他组院内死亡率无差异。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:进一步刻画第三性别群体需要改进健康记录中性别和社会性别的记录流程。
对床旁实践的改变
- 作者认为,进一步刻画第三性别群体需要改进健康记录中性别和社会性别的记录流程。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patient sex affects treatment and outcomes in critical illness. Previous studies of sex differences in critical illness compared female and male patients. In this study, we describe the group of patients classified as a third sex admitted to ICUs in Australia and New Zealand.
RESEARCH QUESTION: What are the admission characteristics and outcomes of ICU patients classified as belonging to a third sex group compared with patients classified as female or male?
STUDY DESIGN AND METHODS: Retrospective observational study of admissions to 200 ICUs, recorded in the Australian and New Zealand Intensive Care Society's Adult Patient Database from 2018 to 2022. We undertook mixed effect logistic regression to compare hospital mortality across the sex groups, adjusted for illness severity, diagnosis, treatment limitation, year, and hospital.
RESULTS: We examined 892,161 admissions, of whom 525 (0.06%) were classified as third sex. Patients classified as third sex were represented across all diagnostic categories, jurisdictions, and hospital types. On average, they were younger than the groups classified as female (59.2 ± 20.0 vs 61.3 ± 18.4 years; P = .02) or male (63.2 ± 16.7 years; P < .001), respectively. Patients classified as third sex were more likely to be admitted after orthopedic surgery (10.1% third sex admissions [95% CI, 7.7%-13.0%]; 6.2% female [95% CI, 6.1%-6.3%]; 4.8% male [95% CI, 4.7%-4.9%]) and drug overdose (8.8% third sex admissions [95% CI, 6.5%-11.5%]; 4.2% female [95% CI, 4.1%-4.2%]; 3.1% male [95% CI, 3.0%-3.1%]). There was no difference in the adjusted hospital mortality of patients classified as third sex compared with the other groups.
INTERPRETATION: Patients classified as third sex composed a small minority group of adult ICU patients. This group had a different diagnostic case mix but similar outcomes to the groups classified as female or male. Further characterizing a third sex group will require improved processes for recording sex and gender in health records.
参考来源
- Modra LJ, Higgins AM, Pilcher DV, et al. Epidemiology of Intensive Care Patients Classified as a Third Sex in Australia and New Zealand. Chest. 2023. PMID: 38081578. doi:10.1016/j.chest.2023.11.043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。